| Bioactivity | PPARγ agonist 12 (compound 9i) is a potent and selective PPARγ agonist with an EC50 of 15.42 μM. PPARγ agonist 12 improves insulin secretion and has anti-diabetic effect[1]. |
| Formula | C25H23N3O6S2 |
| Molar Mass | 525.60 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ali I H, et al. Novel thiazolidin-4-one benzenesulfonamide hybrids as PPARγ agonists: Design, synthesis and In vivo anti-diabetic evaluation[J]. European Journal of Medicinal Chemistry, 2024: 116279. |